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Summary: An outbreak of methicillin-resistant Staphylococcus aureus 
(MRSA) occurred in two adjacent orthopaedic wards following the admission 
of a known carrier. The outbreak was not contained by ward closure or by 
standard infection control measures. Eventually several nasal carriers were 
identified and treated with nasal mupirocin, following which the outbreak 
ended. 
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Introduction 
In many areas of south-east England, methicillin-resistant Staphylococcus 
aureus (MRSA) is now the most noticeable example of cross-infection 
within hospital and the most prevalent form is EMRSA-1 referred to as the 
Thames epidemic strain (Marples, Richardson & de Saxe, 1986). This 
organism is endemic in the hospitals of Southend Health District (Barrett et 
al., 1988), and in so far as infection control precautions are possible, these 
are based on guidelines prepared by a working party of the North-East 
Thames Regional Microbiology Subcommittee (Adhami et al., 1987). 
These guidelines recommend that individuals affected with MRSA should 
be treated with mupirocin, a potent antistaphylococcal agent for topical use 
(Casewell & Hill, 1987). Mupirocin has been found effective in the 
elimination of MRSA when other topical agents such as chlorhexidine have 
been unsuccessful (Hill, Duckworth & Casewell, 1988). This report of 
MRSA in an orthopaedic unit discusses the measures used to contain an 
outbreak and demonstrates the role of nasal mupirocin. 
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Patients and Methods 
Investigation of the outbreak 
Two adjacent orthopaedic wards admitting patients of either sex over the 
age of 14 yrs were involved. The outbreak followed the admission of a 
patient known to be colonized with MRSA (Figure 1, patient 1). Although 
this patient was source-isolated in a side-room, a second case (patient 2) was 
discovered 19 days later. In accordance with the Regional guidelines, all 
staff and patients were then screened for MRSA. Cotton-tipped swabs were 
used for screening of potential carriage sites and were moistened with sterile 
distilled water before application to both anterior nares, both axillae or the 
perineum. Where applicable, swabs were also taken from skin lesions, and 
samples of catheter urine and sputum were examined. In the case of subjects 
found positive for MRSA, a blood agar plate was touched against the scalp 
hair to check for carriage in this site. Six swabs from carriage sites or from 
urine/sputum were streaked on to a blood agar plate and also on to 
mannitol-salt agar (Oxoid), the Oxford staphylococcus was streaked on to 
each plate as a control. A filter-paper disk containing 25 c(g methicillin 
(Mast Laboratories) was overlaid on the mannitol-salt agar and both plates 
were incubated at 37°C for 36 hours. Colonies of staphylococci appearing 
resistant to methicillin were identified using the ‘Staphaurex’ slide 
agglutination test. Suspect colonies of MRSA were then tested in pure 
culture against a methicillin strip using the Oxford staphylococcus as a 
control. Strains growing less than 20 mm from the strip were considered 
methicillin-resistant. Other antibiotic susceptibilities were determined by 
the Stokes method (Stokes & Waterworth, 1972). 
The affected ward was closed when more than two patients were found to 
be carrying MRSA, and thereafter only MRSA-positive patients from 
adjacent ward areas were admitted to it. Screening of all staff and patients 
was repeated four weeks later. 
Control measures 
Each patient found to be MRSA-positive was treated in accordance with the 
Regional guidelines. Patients were isolated either singly or in four-bedded 
side wards. Small areas of broken skin were treated with mupirocin cream; 
larger wounds were treated with aqueous chlorhexidine. Chlorhexidine was 
used to wash the hair if affected, and skin carriage was treated by daily 
bathing with triclosan bath concentrate; patients who could not use a 
bathroom were given bed baths with aqueous chlorhexidine. Mupirocin 
nasal ointment (2% in paraffin base), provided for use in clinical trials by 
Beecham Pharmaceuticals, Brentford, Middlesex, was applied to both 
anterior nares twice daily for five days in cases of nasal carriage. 
Antibacterials were stopped after one week of suppressive treatment and the 
patient was checked for recrudescence of MRSA by reswabbing 3, 6 and 9 
days later. When a ward area had been cleared of MRSA patients it was 
thoroughly cleaned before re-use. The cleaning protocol included washing 
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with a 2% phenolic disinfectant of all beds, mattress and pillow covers, 
ward furniture, level surfaces, floors and walls; all linen and curtains were 
replaced. Bathrooms and toilets were treated with a chlorine-releasing 
cleaning powder. 
Results 
Figure 1 shows the results of swab examination for MRSA for all patients 
who were positive at any time during the outbreak. The initial screening of 
the ward, undertaken after the second patient was detected, revealed two 
additional MRSA-positive patients (patients 3 & 4). No staff member was 
found positive. Despite the application of infection control measures, a 
review of the situation in the middle of August, approximately four weeks 
following ward closure, gave no indication that the outbreak was being 
controlled since of eight patients who had been treated repeatedly with 
suppressive measures, seven had yielded positive specimens within the 
previous week. Only one patient, who had received nasal mupirocin for 
nasal carriage (patient 4), had been cleared of MRSA, and had remained 
clear for approximately five weeks. Following a repeat screening another 
seven cases (patients 9-15) were then detected, five of these had positive 
nasal swabs and in four this was the sole site of colonization. These patients 
were given suppressive treatment including topical or nasal mupirocin 
where indicated. Nasal mupirocin was also given to patient 6 who now 
showed a positive nasal culture for the first time, and to patient 8 whose 
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Figure 1. Swab results from EMRSA patients. N = nose swab; 0 = swab from extranasal 
sites; n positive for EMRSA; 0 negative for EMRSA; H = treatment with nasal mupirocin; 
D = discharged; t = died. 
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Table I. Isolation of MRSAfrom extranasal sites of patients with and without nasal MRSA* 
Site of extranasal MRSA Number of patients Number of patients 
with nasal MRSA without nasal MRSA 
Operative wound 
Pressure sore 
Axilla 
Perineum 
Scalp hair 
Total patients 
5 
i 
: 0 
3 
: 
: 5 
*Patients yielding MRSA from nasal swabs only are not included. 
nasal colonization had inadvertently been left untreated for two weeks; 
patient 9 was discharged before swab results were available. Patients 1, 5, 7, 
12 and 15 never yielded MRSA from nasal culture, the distribution of 
extranasal sites from which MRSA was isolated is shown in Table I. 
Following the widespread introduction of nasal mupirocin on 26 August, 
only three patients yielded positive specimens; patient 10 who was 
terminally ill, and patients 5 and 7 who had MRSA in extranasal sites and 
both of whom later became MRSA-negative. Swabs were taken from 
affected patients at a similar rate both before (0.63 per patient-day) and after 
(O-72 per patient-day) this date and the overall proportion of those yielding 
MRSA decreased from 60/214 to 7/179. No new case of MRSA was 
detected after the introduction of nasal mupirocin and the ward reopened 
three weeks later after a total of eight weeks closure. 
Discussion 
This orthopaedic unit had a long mean patient-stay of 17.7 days, and it was 
necessary for MRSA-positive patients to remain on the ward for long 
periods after detection. The difficulties posed by a large number of patients 
requiring infection control measures may have been responsible for the 
accidental omission of nasal mupirocin from some regimes, although all 
other suppressive measures were applied correctly. The first four patients to 
be detected were isolated and received appropriate suppressive treatment 
apart from patients 2 and 3 whose nasal carriage was inadvertently left 
untreated. Patients 5-8 who were discovered later by routine swabs were 
treated similarly along with the earlier patients, although again one (patient 
8) did not receive nasal mupirocin promptly. Patients 9-15 had been 
MRSA-positive for an unknown period prior to the second staff and patient 
screening on 19 August. The end of the outbreak coincided with the death 
or discharge of patients 1, 2 and 9 and the detection and treatment of 
patients 9-15 as well as with the introduction of nasal mupirocin and it is 
therefore impossible to be certain of the role played by the use of nasal 
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mupirocin. However, since standard infection control measures had proved 
ineffective in the early stages of the outbreak, it seems likely that the failure 
to control the outbreak was related to inadequate treatment of nasal MRSA 
in identified patients, and the presence of unidentified nasal carriers; the 
problem may have been compounded by transient nasal carriage which was 
shown by at least two patients (2 and 3). This outbreak was controlled 
although enrichment culture was not used when examining for MRSA 
colonization; enrichment culture has been found to contribute little to the 
control of at least one outbreak (Hill et al., 1988). 
The propensity for patient-to-patient spread shown by the Thames 
epidemic MRSA has resulted in many hospital outbreaks (Marples & 
Cooke, 1985) and guidelines for its control have been produced by working 
parties of the Hospital Infection Society/British Society for Antimicrobial 
Chemotherapy (Ayliffe et al., 1986) and of the North East Thames Regional 
Health Authority (Adhami et al., 1987). The value of nasal mupirocin in the 
elimination of Staphylococcus aureus was demonstrated by Casewell and Hill 
(1986) and this agent has been included in both the above sets of guidelines. 
Nasal mupirocin was considered of value in the control of ward and hospital 
outbreaks of MRSA by Dacre, Emmerson & Jenner (1986) and by Hill et al. 
(1988), and in the control of an outbreak of MRSA in an endemic situation 
in a Special Care Baby Unit (Davies et al., 1988). 
In these and other reports the agent was used, as in the present study, as 
one of a number of infection control measures likely to have aided control of 
spread of MRSA, although Hill et al. (1988) also noted a reduction in 
extranasal MRSA following the use of nasal mupirocin. The particular 
interest of the present report is that the number of patients involved 
continued to increase despite standard treatment until several nasal carriers 
were discovered and then treated with nasal mupirocin. After this time the 
outbreak rapidly came under control and it therefore seems likely that this 
agent played an important part, over and above that of standard measures, 
in terminating the outbreak. 
I am grateful for the advice and assistance of Professor A. M. Emmerson and Mrs J. Catton. 
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